Free Trial

LENZ Therapeutics (LENZ) Insider Trading & Ownership

$21.03
+1.42 (+7.24%)
(As of 07/12/2024 ET)

LENZ Therapeutics (NASDAQ:LENZ) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
38.40%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$15.50 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get LENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LENZ Insider Buying and Selling by Quarter

LENZ Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2024James W MccollumDirectorBuy31,332$15.99$500,998.68  
3/21/2024Ra Capital Management, L.P.DirectorBuy998,009$15.03$15,000,075.27  
(Data available from 1/1/2013 forward)

LENZ Insider Trading Activity - Frequently Asked Questions

Who is on LENZ Therapeutics's Insider Roster?

The list of insiders at LENZ Therapeutics includes James W Mccollum, and Ra Capital Management, L.P.. Learn more on insiders at LENZ.

What percentage of LENZ Therapeutics stock is owned by insiders?

38.40% of LENZ Therapeutics stock is owned by insiders. Learn more on LENZ's insider holdings.

Which LENZ Therapeutics insiders have been buying company stock?

The following insiders have purchased LENZ shares in the last 24 months: James W Mccollum ($500,998.68), and Ra Capital Management, L.P. ($15,000,075.27).

How much insider buying is happening at LENZ Therapeutics?

Insiders have purchased a total of 1,029,341 LENZ shares in the last 24 months for a total of $15,501,073.95 bought.


This page (NASDAQ:LENZ) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners